Issue 2/2009
Content (13 Articles)
The emerging role of TRIB3 as a gene affecting human insulin resistance and related clinical outcomes
Sabrina Prudente, Eleonora Morini, Vincenzo Trischitta
Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities
Eugenia Resmini, Francesco Minuto, Annamaria Colao, Diego Ferone
Insulin resistance and exercise capacity in male children and adolescents with non-alcholic fatty liver disease
Melania Manco, Ugo Giordano, Attilio Turchetta, Rodolfo Fruhwirth, Monica Ancinelli, Matilde Marcellini, Valerio Nobili
Effects of pentoxifylline and pentosan polysulphate combination therapy on diabetic neuropathy in type 2 diabetes mellitus
Boglárka Laczy, Judit Cseh, Márton Mohás, Lajos Markó, Mónika Tamaskó, Tamás Kőszegi, Gergő A. Molnár, Zoltán Wagner, László Wagner, István Wittmann
The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
A. Nar, O. Gedik
Bone biomechanical and histomorphometrical investment in type 2 diabetic Goto-Kakizaki rats
Liping Zhang, Yaping Liu, Dong Wang, Xinbo Zhao, Zhanjun Qiu, Hong Ji, Haiqin Rong
Association of C-reactive protein and hyperuricemia with diabetic nephropathy in Chinese type 2 diabetic patients
Chen-Chung Fu, Du-An Wu, Ji-hung Wang, Wen-Chin Yang, Chin-Hsiao Tseng
Semicarbazide-sensitive amine oxidase activity and total nitrite and nitrate concentrations in serum: novel biochemical markers for type 2 diabetes?
Sandra Fernanda Nunes, Isabel Vitoria Figueiredo, Paulo João Soares, Nuria Espriu Costa, Maria Celeste Lopes, Maria Margarida Caramona
Serum glycated albumin levels are influenced by smoking status, independent of plasma glucose levels
Masafumi Koga, Hiroshi Saito, Mikio Mukai, Michio Otsuki, Soji Kasayama
The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis
Kevin M. Pantalone, Michael W. Kattan, Changhong Yu, Brian J. Wells, Susana Arrigain, Anil Jain, Ashish Atreja, Robert S. Zimmerman
Letter to the Editor re: the Letter to the Editor by Dr. David Samuel Henry Bell, MD regarding “The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis”
Robert S. Zimmerman, Kevin Matthew Pantalone
Cardiometabolic risk and educational level in adult patients with type 1 diabetes
J. Nádas, Z. Putz, J. Fövényi, Z. Gaál, A. Gyimesi, T. Hídvégi, N. Hosszúfalusi, G. Neuwirth, T. Oroszlán, P. Pánczél, G. Vándorfi, G. Winkler, I. Wittmann, G. Jermendy